Markets
Bald eagle
A stoic bald eagle ponders the US’s loss of creditworthiness (Rene Nijhuis/Getty Images)
USAa1

The US government just lost its final AAA credit rating

Aa1 just doesn’t have the same ring to it.

Luke Kawa

Moody’s, the last credit ratings agency to bestow the US government with a pristine credit rating, is taking away that title.

The decision “reflects the increase over more than a decade in government debt and interest payment ratios to levels that are significantly higher than similarly rated sovereigns,” Moody’s said in a statement announcing the drop to Aa1 from AAA. “We do not believe that material multi-year reductions in mandatory spending and deficits will result from current fiscal proposals under consideration.”

Ten-year Treasury yields jumped as much as 6 basis points, reaching levels not seen since 10:00 a.m. Thursday, in the minutes following the announcement.

With all due respect to Fitch, which downgraded the US in August 2023, the more momentous downgrade that will stick in people’s minds is the August 2011 cut by S&P in the midst of debt ceiling drama that sparked fears of a potential default.

But bond yields largely fell in the wake of that announcement, because, frankly, the macroeconomic backdrop is always going to be a much larger driver of Treasuries than dictates of ratings agencies. Investors were very worried about a double-dip recession about two years removed from the end of the economic contraction tied to the global financial crisis of 2008, and sought safety in US bonds because that’s what you want to own when you’re worried about the economy.

Time has passed; circumstances have evolved. In 2022, we had a bear market in stocks where bonds offered no protection because high inflation and aggressive Fed rate hikes to try to tamp down price pressures were driving investor angst.

Right now, tariffs (which push prices higher and activity lower) remain a risk to the outlook, and are not obviously bond-positive.

Couple that with a market that has recently flirted with the idea that US exceptionalism is past its peak and you have a recipe for this downgrade to potentially leave a more enduring mark. Or not.

(The good news is that the “sell America” theme has largely manifested as “hedge America” — that is, investors are maintaining holdings of US stocks and bonds, but hedging away the US dollar exposure.)

“While survey respondents are near historic USD shorts, they have not meaningfully rotated out of US duration,” Bank of America analysts wrote in a May 9 note. “This suggests that ‘de-dollarization’ may be playing out more through hedge ratios than asset reallocation.”

While my personal view is that ratings agencies exist to a) allow people to avoid doing their own due diligence, and b) be made fun of given their history (TL;DR: watch “The Big Short”), it is also true in many cases that investment funds have limitations on what they can hold based on their credit ratings.

However, there are also often special allowances made with regard to holding US Treasuries or merely distinctions made solely between investment grade and non-investment grade debt, which makes the above more pertinent to corporate and emerging market investment holdings.

More Markets

See all Markets
markets

Nike’s China business declines for seventh straight quarter

Sportswear kingpin Nike reported results for its third quarter, which ended in February, after the bell Tuesday. The stock fell about 3% in after-hours trading.

For fiscal Q3, Nike reported:

  • Earnings of $0.35 per share, comfortably above the Wall Street consensus of $0.29 per share compiled by FactSet.

  • $11.28 billion in total revenue, roughly in line with the $11.26 billion estimate.

Nike’s sales in China — where the company earns about 15% of its revenue — fell 7% to $1.62 billion. That’s its seventh straight quarter of sales declines in the market, though this quarter’s was less than feared. The company had issued weak guidance for this quarter considering continued softness in the region.

“This quarter we took meaningful actions to improve the health and quality of our business,” said Nike CEO Elliott Hill. “The pace of progress is different across the portfolio and the areas we prioritized first continue to drive momentum.”

Nike shares are trading near decade lows this month, as tariffs continue to weigh on profits and shipping costs rise amid the war with Iran. As of Tuesday’s close, the stock was down 17% year to date.

Oil-sensitive travel stocks pop following Iran state media reporting on potential war resolution

Travel stocks are surging on Tuesday as oil prices fall following reports from Iranian state media that President Masoud Pezeshkian said the country has the necessary will to end this war, but would only do so with guarantees that prevent the recurrence of aggression.

The war has sent oil prices and refining margins surging this month, causing airlines and cruise lines to cut profit forecasts despite reported high demand.

Following Tuesday’s update, shares of the big four US airlines (Delta Air Lines, United Airlines, American Airlines, and Southwest Airlines) all climbed, along with smaller rivals including JetBlue. US airlines have stopped fuel hedging in recent years, increasing their exposure to upward swings in oil prices.

Cruise stocks also rallied, with Carnival and Norwegian up more than 6% and Royal Caribbean up about 5%.

markets

The FDA is expected to lift restrictions on certain peptides, the NYT reports

The Food and Drug Administration is expected to lift restrictions on certain peptides, allowing the experimental, often injectable substances to be sold by compounding pharmacies, The New York Times reported Tuesday.

The potential move was previously reported by The Wall Street Journal, and teased by Health Secretary Robert F. Kennedy Jr. on the “Joe Rogan Experience” podcast in late February.

Peptides have boomed in popularity recently, with search interest for “peptides” surpassing “ozempic” this month. Many of them are currently understudied and not approved for human use, a rule consumers are able to bypass by purchasing them from suppliers that sell them for, ostensibly, research purposes only.

As reports of the FDA changing its stance of peptides mount, consumer health companies like Hims & Hers and Superpower have been getting ready to roll out their peptide offerings as soon as they get the FDA's blessing.

Peptides have boomed in popularity recently, with search interest for “peptides” surpassing “ozempic” this month. Many of them are currently understudied and not approved for human use, a rule consumers are able to bypass by purchasing them from suppliers that sell them for, ostensibly, research purposes only.

As reports of the FDA changing its stance of peptides mount, consumer health companies like Hims & Hers and Superpower have been getting ready to roll out their peptide offerings as soon as they get the FDA's blessing.

markets

Memory stocks bounce as Bernstein analyst calls TurboQuant fears “overdone”

Memory stocks rose Tuesday, after Bernstein analysts called the recent panic over Google’s TurboQuant AI algorithm “overdone.”

Bernstein analyst Mark Newman wrote:

“[Hard disk drive] and Memory stocks have sold off significantly due in part to fears from Google’s TurboQuant report. This however, should have zero impact on HDD demand and negligible impact on NAND demand. Given the stock sell-off we see this as an attractive entry point for Seagate Technology Holdings, Western Digital and Sandisk’s and upgrade WDC to Outperform.”

All three stocks were up early Tuesday, as was memory chip maker Micron.

Todays rally stands in stark contrast to the pummeling these shares have endured over the last week, after Google Research published a technical paper on March 24 detailing its TurboQuant AI algorithm, which compresses the amount of data associated with AI operations without affecting the accuracy of AI models.

That was seen as a threat to surging AI demand for memory storage, which has supercharged prices for memory chips and memory-related stocks over the last year.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, Robinhood Derivatives, LLC, or Robinhood Money, LLC. Futures and event contracts are offered through Robinhood Derivatives, LLC.